×
Search
[custom_company_search_form]
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%
Iron Ore
101.10
0.01%
Lithium
42.74
1.28%
Gold
2,645.50
0.28%
Copper
4.11
(0.05%)
Oil
70.48
0.4%
Bitcoin
95,554.83
(3.85%)
USD/AUD
0.62
(0.14%)
FTSE 100
8,137.00
0.42%
Nikkei 225
39,568.06
1.12%
Dow Jones
43,297.03
0.89%
Hang Seng
20,098.29
0.94%

Imricor Medical Systems Inc

IMR

ASX

Imricor Medical Systems, Inc. (IMR) is a developer of innovative MRI-compatible medical devices which can be used to carry out real-time iCMR cardiac ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities around the world by increasing the success rates and bringing down the overall costs of cardiac ablation procedures.

Latest Posts

Line Chart with Gradient
Price
$1.095
-0.01 (-0.9%)
At Close 24/12 (AEST)
Related Companies
SDI LIMITED
$SDI
MEDADVISOR LIMITED
$MDR
EMVISION MEDICAL DEVICES LTD
$EMV
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
$FPH
COMPUMEDICS LIMITED
$CMP

Leave a Comment on IMR


Comments for IMR

    Latest Posts

    imricor-medical-systems-asx-imr-advances-northstar-3d-mapping-system-imr
    Health Care $IMR
    Imricor Medical Systems (ASX: $IMR) advances NorthStar 3D Mapping SystemNorthStar 3D Mapping System submitted for CE Mark and FDA approval to enhance MRI-guided procedures
    December 23, 2024
    imricor-medical-systems-asx-imr-signs-agreement-for-ai-module-integration-imr
    Health Care $IMR
    Imricor Medical Systems (ASX: $IMR) signs agreement for AI module integrationPartnership with ADIS SA to enhance NorthStar 3D mapping system with advanced AI technology
    November 28, 2024
    imricor-medical-systems-asx-imr-reinstatement-to-quotation-imr
    Health Care $IMR

    Imricor Medical Systems (ASX: $IMR) reinstatement to quotation

    IMR to resume trading following proposed capital raising announcement

    August 21, 2024
    imricor-asx-imr-pauses-tga-process-to-wait-for-second-generation-vision-mr-ablation-catheter-imr
    Health Care $IMR

    Imricor (ASX: $IMR) pauses tga process to wait for second-generation vision-mr ablation catheter

    Withdraws application for TGA approval of first-generation catheter, plans for release of Gen 2 in 2025

    August 13, 2024
    imricor-asx-imr-treats-first-patient-in-the-united-states-imr
    Health Care $IMR

    Imricor (ASX: $IMR) treats first patient in the united states

    Johns Hopkins initiates enrolment in VISABL-AFL trial for Imricor's iCMR-guided ablation procedure

    August 7, 2024
    imricor-asx-imr-executes-global-expansion-and-achieves-significant-revenue-growth-imr
    Health Care $IMR

    Imricor (ASX: $IMR) executes global expansion and achieves significant revenue growth

    Company progresses with clinical trials and installations, reports substantial revenue increase in Q2

    July 31, 2024
    imricor-asx-imr-performs-second-icmr-guided-atrial-flutter-ablation-at-dubrava-university-hospital-imr
    Health Care $IMR

    Imricor (ASX: $IMR) performs second iCMR-guided atrial flutter ablation at Dubrava University Hospital

    Dubrava University Hospital orders additional catheter kits to support volume ramp up

    June 28, 2024
    imricor-asx-imr-receives-final-approval-for-visabl-afl-trial-at-lausanne-university-hospital-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives final approval for visabl-afl trial at lausanne university hospital

    Swiss competent authority approves clinical trial for US FDA approval

    May 10, 2024
    imricor-asx-imr-receives-first-catheter-order-from-dubrava-university-hospital-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives first catheter order from Dubrava University Hospital

    Dubrava University Hospital orders first set of Imricor catheters, MRI software upgrade to enable real-time imaging

    April 11, 2024
    imricor-asx-imr-receives-final-approval-for-visabl-afl-trial-at-cardiovascular-institute-of-south-paris-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives final approval for visabl-afl trial at cardiovascular institute of south paris

    French Competent Authority approves VISABL-AFL clinical trial at ICPS for US FDA approval

    April 10, 2024
    imricor-asx-imr-restarts-mri-guided-procedures-with-northstar-3d-mapping-system-imr
    Health Care $IMR

    Imricor (ASX: $IMR) restarts mri guided procedures with northstar 3d mapping system

    Amsterdam UMC resumes routine atrial flutter procedures using Imricor's NorthStar 3D mapping system

    April 5, 2024
    imricor-asx-imr-receives-fda-approval-for-northstar-3d-mapping-system-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives FDA approval for NorthStar 3D mapping system

    NorthStar 3D mapping system approved for use in VISABL-AFL clinical trial

    March 26, 2024
    imricor-asx-imr-receives-ethics-approval-for-visabl-afl-clinical-trial-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives ethics approval for VISABL-AFL clinical trial

    Lausanne University Hospital approves Imricor's VISABL-AFL trial, supporting US FDA approval

    March 8, 2024
    imricor-asx-imr-receives-ce-mark-approval-to-sell-into-europe-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives ce mark approval to sell into europe

    Vision-MR Diagnostic Catheter approved for sale in EU, manufacturing to begin in April

    March 6, 2024
    imricor-medical-systems-inc-asx-imr-reports-decrease-in-revenue-and-increased-net-loss-imr
    Health Care $IMR

    Imricor Medical Systems, Inc. (ASX: $IMR) reports decrease in revenue and increased net loss

    Preliminary final report reveals challenges in sales and need for additional working capital

    February 29, 2024
    imricor-medical-systems-asx-imr-completes-retail-entitlement-offer-imr
    Health Care $IMR

    Imricor Medical Systems (ASX: $IMR) completes retail entitlement offer

    Retail Entitlement Offer closed with valid applications for 1,419,069 New Shares

    February 27, 2024
    imricor-medical-systems-asx-imr-requests-voluntary-suspension-for-capital-raising-update-imr
    Health Care $IMR

    Imricor Medical Systems (ASX: $IMR) requests voluntary suspension for capital raising update

    Company seeks temporary halt to trading pending material announcement on proposed capital raising

    February 3, 2024
    imricor-asx-imr-receives-approval-for-commercialization-in-saudi-arabia-imr
    Health Care $IMR

    Imricor (ASX: $IMR) receives approval for commercialization in saudi arabia

    Set to launch commercialization efforts in KSA with Medical Device Marketing Authorization

    January 12, 2024
    imricor-medical-systems-asx-imr-reaches-milestone-for-mri-system-imr
    Health Care $IMR
    Imricor Medical Systems (ASX: $IMR) reaches milestone for MRI systemPlans underway for NorthStar 3D mapping system launch with Philips MRI compatibility

    October 17, 2024

    IMR

    $IMR

    Imricor (ASX: $IMR) restarts mri guided procedures with northstar 3d mapping system

    Amsterdam UMC resumes routine atrial flutter procedures using Imricor's NorthStar 3D mapping system

    IMR

    $IMR

    Imricor (ASX: $IMR) receives FDA approval for NorthStar 3D mapping system

    NorthStar 3D mapping system approved for use in VISABL-AFL clinical trial

    IMR

    $IMR

    Imricor (ASX: $IMR) receives ethics approval for VISABL-AFL clinical trial

    Lausanne University Hospital approves Imricor's VISABL-AFL trial, supporting US FDA approval

    IMR

    $IMR

    Imricor (ASX: $IMR) receives ce mark approval to sell into europe

    Vision-MR Diagnostic Catheter approved for sale in EU, manufacturing to begin in April

    IMR

    $IMR

    Imricor Medical Systems, Inc. (ASX: $IMR) reports decrease in revenue and increased net loss

    Preliminary final report reveals challenges in sales and need for additional working capital

    IMR

    $IMR

    Imricor Medical Systems (ASX: $IMR) completes retail entitlement offer

    Retail Entitlement Offer closed with valid applications for 1,419,069 New Shares

    IMR

    $IMR

    Imricor Medical Systems (ASX: $IMR) requests voluntary suspension for capital raising update

    Company seeks temporary halt to trading pending material announcement on proposed capital raising

    IMR

    $IMR

    Imricor (ASX: $IMR) receives approval for commercialization in saudi arabia

    Set to launch commercialization efforts in KSA with Medical Device Marketing Authorization

    Load More
    No More Posts
    Related Companies
    SOMNOMED LIMITED
    $SOM
    HITIQ LIMITED
    $HIQ
    POLYNOVO LIMITED
    $PNV
    APIAM ANIMAL HEALTH LIMITED
    $AHX
    PACIFIC SMILES GROUP LIMITED
    $PSQ

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions